The McGill Innovation Fund (MIF) is back for a 6th year. The largest entrepreneurial funding competition at McGill, the MIF has supported over 30 unique teams and awarded close to $2 million in...
A breath-based test for infectious diseases that offers a less invasive alternative to nasal swabs is among eight innovations awarded prizes at the 2026 McGill Clinical Innovation Competition (CLIC...
McGill researchers have developed a diagnostic system capable of identifying bacteria –and determining which antibiotics can stop them – in just 36 minutes, a major advance in the global effort to...
The AMR data repository, hosted by the Infectious Diseases Data Observatory (IDDO), now covers nearly 70 countries and 783,000 patients, after launching last year to provide a secure, sustainable...
Life just got more difficult for those fighting antibiotic-resistant superbugs. Researchers at McGill University have discovered two enzymes that use a never-before-seen mechanism to confer...
Entrepreneurial spirit is thriving at McGill, as shown by a record-breaking 31 applications to the McGill Innovation Fund (MIF) this year. Since its inception in 2020, the MIF has been a catalyst...
Antimicrobial resistance (AMR) is one of the top ten global health threats and poses a major risk to public health and the economy. As the threat continues to increase, it is vital that...
The world is on the brink of a silent pandemic—one where currently treatable infections risk becoming once again life-threatening. This looming danger is Antimicrobial Resistance (AMR), a...